Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain

被引:68
作者
Moret, C
Briley, M
机构
[1] Centre de Recherche Pierre Fahre, 81100 Castres
关键词
5-HT; (5-hydroxytryptamine; serotonin); 5-HT uptake inhibitor; antidepressant; microdialysis; hypothalamus; rat;
D O I
10.1016/0014-2999(95)00646-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of acute (2 days) and repeated (21 days) administration (50 mg/kg in the diet) of the selective serotonin (5-HT, 5-hydroxytryptamine) reuptake inhibitor, citalopram, on extracellular levels of 5-HT and their modulation by terminal autoreceptors in the hypothalamus of freely moving rats were compared in vivo by microdialysis. When studied without washout, extracellular levels of 5-HT were increased by both acute and repeated citalopram administration. In rats treated repeatedly, extracellular 5-HT levels were 43% (but not significantly) greater than in those treated acutely. Extracellular levels of 5-HT in control and citalopram-treated rats were similar when measured after 24 h washout. The enhancing effect of non-selective serotonergic autoreceptor antagonists, methiothepin (100 mu M) or 1-(1-naphthyl)piperazine (NP) (10 mu M), administered through the microdialysis probe, after 24 h washout, was similar in both control and chronically treated groups. These results suggest that repeated administration of citalopram followed by a washout of 24 h does not lead to desensitization of the terminal autoreceptor as measured in vivo in contrast to the effects we have shown previously in vitro. In rats treated chronically with citalopram without washout, methiothepin had a greater maximal effect on 5-HT outflow in comparison to rats receiving acute citalopram treatment. This finding suggests that a 5-HT autoreceptor antagonist or a combination of such a drug with a 5-HT uptake inhibitor would produce a greater increase of extracellular levels of 5-HT in hyposerotonergic states such as depression.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 27 条
[1]   CHRONIC TREATMENT WITH FLUVOXAMINE INCREASES EXTRACELLULAR SEROTONIN IN FRONTAL-CORTEX BUT NOT IN RAPHE NUCLEI [J].
BEL, N ;
ARTIGAS, F .
SYNAPSE, 1993, 15 (03) :243-245
[2]   CHRONIC TREATMENT WITH FLUVOXAMINE BY OSMOTIC MINIPUMPS FAILS TO INDUCE PERSISTENT FUNCTIONAL-CHANGES IN CENTRAL 5-HT1A AND 5-HT1B RECEPTORS, AS MEASURED BY IN-VIVO MICRODIALYSIS IN DORSAL HIPPOCAMPUS OF CONSCIOUS RATS [J].
BOSKER, FJ ;
VANESSEVELDT, KE ;
KLOMPMAKERS, AA ;
WESTENBERG, HGM .
PSYCHOPHARMACOLOGY, 1995, 117 (03) :358-363
[3]   NEUROBIOLOGICAL MECHANISMS INVOLVED IN ANTIDEPRESSANT THERAPIES [J].
BRILEY, M ;
MORET, C .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) :387-400
[4]   SEROTONIN RELEASE ESTIMATED BY TRANSCORTICAL DIALYSIS IN FREELY-MOVING RATS [J].
CARBONI, E ;
DICHIARA, G .
NEUROSCIENCE, 1989, 32 (03) :637-645
[5]   EFFECTS OF A SELECTIVE 5-HT REUPTAKE BLOCKER, CITALOPRAM, ON THE SENSITIVITY OF 5-HT AUTORECEPTORS - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
CHAPUT, Y ;
DEMONTIGNY, C ;
BLIER, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (04) :342-348
[6]  
CHAPUT Y, 1988, ADV BIOL PSYCHIAT, V17, P1
[7]  
Feighner J P., 1991, Selective serotonin re-uptake inhibitors: the clinical use o f Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
[9]  
GALZIN AM, 1985, J PHARMACOL EXP THER, V235, P200
[10]  
HAMON M, 1988, J PHARMACOL EXP THER, V246, P745